Tesla Just Spent $4.73 Billion on Capex. Here's Where Every Dollar Went.

Tesla spent $4.73 billion on capex in Q3, more than double the year-earlier $2.25 billion but below the roughly $7.5 billion expected, and cut its full-year capex forecast from over $25 billion to about $20 billion. Q3 operating cash flow was $6.26 billion and free cash flow was $1.53 billion, while net income fell 43% to $787 million on essentially flat revenue of $28.1 billion; the company ended the quarter with $45.4 billion in cash and investments. Spending is directed toward AI and autonomous vehicles, Optimus, energy storage, and the Terafab semiconductor project; energy storage deployments rose about 10% year over year to 13.7 GWh. The article sees substantial potential but notes that projected returns depend on execution, adoption, and regulatory approval.

Analysis

The capex undershoot is near-term cash-flow supportive, but it should not be read as evidence that Tesla’s new businesses are becoming more efficient: it may instead reflect pacing and prioritization. With core earnings weakening, the key risk is that incremental dollars move from relatively legible vehicle operations into several capital-intensive bets whose returns arrive on different timelines. That raises the hurdle rate for each project and makes capital allocation—not headline revenue potential—the central diligence question.

Energy storage is the most investable leg because demand and orders are already observable; AI data-center power needs could support continued demand, but competition from integrators such as Fluence and cell suppliers such as CATL may limit returns. Robotaxis, Optimus and in-house chipmaking have much higher execution and regulatory uncertainty. Terafab is especially difficult to underwrite until Tesla discloses cost, schedule and sourcing requirements; it could absorb capital without creating a near-term commercial product. Longer term, if these programs proceed together, skilled labor, power availability and specialized equipment become constraints as well as costs.

Over days, the lower spend plan can support the stock’s cash-flow narrative. Over the next 1–3 months, watch project-level capex disclosure and operating cash flow; over 6–18 months, utilization, paid software adoption, robotaxi approvals and storage margins matter more than capacity announcements. The contrarian risk is that investors treat the capex reduction as discipline while commercialization is simply being deferred. A sustained deterioration in operating cash flow or another earnings decline without measurable deployment progress would falsify the constructive cash-management thesis.

Key Decisions for Investors

• Do not chase the immediate positive reaction on capex restraint alone; keep TSLA exposure neutral until the next reporting cycle clarifies which projects were delayed and whether operating cash flow is holding up.
• For an existing TSLA position, consider a defined-risk downside hedge into the next earnings catalyst if the stock continues to price in successful robotaxi and Optimus commercialization; avoid an outright short absent evidence of further estimate cuts.
• Track energy-storage deployment, backlog conversion and margins separately from AI/robotics announcements. Strong conversion with stable cash generation would support the investment case; rising commitments without delivered deployments would argue for reducing exposure.
• Reassess if Tesla discloses material Terafab cost or schedule escalation, if regulatory approvals for robotaxi operations slip, or if operating cash flow weakens while capex remains elevated.